Forward-looking statements relate to future events and typically address 3Ms expected future business and financial performance. Neogen To Participate In The 43Rd Annual William Blair Growth Stock Stock Price data may be delayed up to 15 minutes. corporate governance. 3M - 3M Statement Regarding Bankruptcy Court Decision Any forward-looking statements speak only as of the date of this communication. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. They may contain forward-looking information about 3Ms financial results, estimates and business prospects that involve substantial risks and uncertainties that could cause actual results to differ materially. The brands listed above are trademarks of 3M. To access them, along with the event webcast link, please visit the Events & Presentations section at neogen.com/investor-relations/events-presentations. NEOGEN's expected pro forma net leverage ratio at close is expected to be less than 2.5x, inclusive of the $1 billion of new debt. By providing your email address below, you are providing consent to 3M to send you the requested Investor Email Alert updates. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." Bldg. NEOGEN to Combine 3M's Food Safety Business With its Existing Conversion of Exercise of derivative security at price 15.62 per share. Investor Contacts. Information about the directors and executive officers of 3M may be found in its Annual Report on Form 10-K filed with the SEC on February 4, 2021, and its definitive proxy statement relating to its 2021 Annual Meeting of Stockholders filed with the SEC on March 24, 2021. Stockhouse.com is owned by Stockhouse Publishing Ltd. 2019 Stockhouse Publishing Ltd. All rights reserved. In 2000, our first successful project was born. The information on this website, including any documents posted herein, contains a significant amount of information about 3M. Presentation materials will be posted to the Neogen Investor Relations website on the morning . Your cart will not be moved to the selected region. 620 Lesher Place, Lansing, MI 48912 ir@NEOGEN.com. Announcements. This communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. 3M - 3M Sets Final Exchange Ratio in Split-Off Exchange Offer in The live webcast can be accessed through Neogen's Investor Relations webpage, neogen.com/investor-relations, under the "Events & Presentations" subheading. Important Information About the Transaction and Where to Find It. NEOGEN's President and Chief Executive Officer, John Adent, and NEOGEN's existing management team will continue to lead the combined company. Neogen to Participate in the 43rd Annual William Blair Neogen to Participate in the 43rd Annual William Blair Growth - ADVFN investorrelations@3M.com. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. View our Investor Presentation for a quick synopsis of why we believe NEOGEN remains a solid choice for investors including the innovative food and animal safety solutions that we offer to our expanding markets. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) that one or more closing conditions to the transaction, including certain regulatory approvals, may not be satisfied or waived, on a timely basis or otherwise, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the proposed transaction, may require conditions, limitations or restrictions in connection with such approvals or that the required approval by the stockholders of NEOGEN may not be obtained; (2) the risk that the proposed transaction may not be completed on the terms or in the time frame expected by NEOGEN, 3M and SpinCo, or at all; (3) unexpected costs, charges or expenses resulting from the proposed transaction; (4) uncertainty of the expected financial performance of the combined NEOGEN SpinCo company following completion of the proposed transaction; (5) failure to realize the anticipated benefits of the proposed transaction, including as a result of delay in completing the proposed transaction or integrating the businesses of NEOGEN and SpinCo, on the expected timeframe or at all; (6) the ability of the combined NEOGEN-SpinCo company to implement its business strategy; (7) difficulties and delays in the combined NEOGEN-SpinCo company achieving revenue and cost synergies; (8) inability of the combined company to retain and hire key personnel; (9) the occurrence of any event that could give rise to termination of the proposed transaction; (10) the risk that stockholder litigation in connection with the proposed transaction or other litigation, settlements or investigations may affect the timing or occurrence of the proposed transaction or result in significant costs of defense, indemnification and liability; (11) evolving legal, regulatory and tax regimes; (12) changes in general economic and/or industry specific conditions; (13) actions by third parties, including government agencies; (14) the risks that the anticipated tax treatment of the proposed transaction is not obtained; (15) the risk of greater than expected difficulty in separating the business of SpinCo from the other businesses of 3M; (16) risks related to the disruption of management time from ongoing business operations due to the pendency of the proposed transaction, or other effects of the pendency of the proposed transaction on the relationship of any of the parties to the transaction with their employees, customers, suppliers, or other counterparties; and (17) other risk factors detailed from time to time in NEOGEN and 3M's reports filed with the SEC, including NEOGEN and 3M's annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and other documents filed with the SEC, including documents that will be filed with the SEC in connection with the proposed transaction. The conference call can be accessed by dialing 1.844.757.5681 (U.S.) or 1.412.317.5297 (International) and requesting the Neogen Corporation Second Quarter FY23 Earnings Call (Conference ID: 10173804). Financial Performance. Stockhouse membership requires an email address which must be shared by Facebook. LANSING, Mich., March 16, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Thursday, March 30, 2023.. Shareholding Pattern. https://www.prnewswire.com/news-releases/neogen-to-participate-in-the-43rd-annual-william-blair-growth-stock-conference-301837749.html. Presentation materials will be posted to the Neogen Investor Relations website on the morning of June 6. Financial Performance & Presentation. None of NEOGEN, 3M or SpinCo undertakes, and each party expressly disclaims, any obligation to update any forward-looking statements, whether as a result of new information or development, future events or otherwise, except as required by law. John Adent, Neogen's President and Chief Executive Officer, will present at 4:00 p.m. Central Time. Governance Resources News Details View all Press Releases 3M Finalizes Separation of its Food Safety Business and Merger of the Business with Neogen; Accepts Shares Tendered in Exchange Offer September 1, 2022 ST. Your cart will not be moved to the selected region. Neogen Shareholders Approve All Proposals Required for Combination with The Company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. INVESTOR RELATIONS. To access them, along with the event webcast link, please visit the Events & Presentations section at neogen.com/investor-relations/events-presentations. Neogen Investor Relations Contact Bill Waelke 620 Lesher Place, Lansing, MI 48912 ir@Neogen.com Transfer Agent and Registrar American Stock Transfer & Trust 59 Maiden Lane, New York, NY 10038 800.937.5449 amstock.com Contact Us First Name* Last Name* Email* Phone Company Address City State/Province Postal Code Country* Comments 800.937.5449 amstock.com. The Company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Because the exchange offer will be subject to proration if the exchange offer is oversubscribed, the number of shares of 3M common stock that 3M accepts in the exchange offer may be less than the number of shares validly tendered by 3M stockholders. Please continue to the site for all other users. September 27, 2022 - Neogen Announces CFO Transition. If the exchange offer is consummated but not fully subscribed, 3M will distribute the remaining shares of SpinCo common stock on a pro rata basis to 3M stockholders as of 5:00 p.m. Eastern time on August 31, 2022 whose shares of 3M common stock remain outstanding after the completion of the exchange offer. The third quarter marked the 123rd of the past 129 quarters that Neogen reported revenue increases compared to the same quarter in the prior year. Insider Transactions Reported - Last Two Years. Bill Waelke, Investor Relations 517.372.9200, BWaelke@Neogen.com Cision View original content:. , , , , , , Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, neogen.com/investor-relations/events-presentations, Neogen Launches New Assays for Histamine Detection, Neogen Launches New Assays for Natural Toxin Detection.